Palavra-chave: IMATINIB

POLYMORPHISMS LASOR LEUCEMIA MIELÓIDE CRÔNICA (LMC-PB) OBSERVATIONAL CHRONIC MYELOID LEUKEMIA IRS-1 MYELOGENOUS LEUKEMIA CITARABINA LOW EDUCATION LEVEL CML TREATMENT-FREE REMISSION BRAZIL KIT K5091 CYTOGENETIC REMISSION BCR-ABL DISCONTINUATION MITOXANTRONE VIRAL HEPATITIS REACTIVATION LEUCEMIA MIELÓIDE CRÔNICA (LMC) LEUCEMIA MIELÓIDE CRÔNICA NON-MYELOABLATIVE CHRONIC MYELOID LEUCEMIA (CML) TYROSINE KINASE INHIBITORS CHRONIC MYELOID LEUKAEMIA EUTOS SCORE CHRONIC MEYLOID LEUKEMIA BCL/ABL FIRST-LINE CYTARABINE START LALNET MOLECULAR RESPONSE DASATINIB-TREATED FRONTLINE LEUCEMIA MIELOIDE CRÔNICA CHRONIC MYELOID LEUCEMIA LEUCEMIA MIELÓDE CRÔNICA OCULAR PHARMAECONOMIC STUDY GENERIC CHRONIC MYELOGENOUS LEUKEMIA CML-CP CRONIC LYMPHOCYTIC LEUKEMIA PROTEIN-CODING PHASE 2 RNAS MR4.5 BCR/ABL CHILDREN AND ADOLESCENTS STEM CELL TRANSPLANTATION CYTOGENETIC BCR-ABL MUTATIONS F359V K562 CELLS CHRONIC PHASE MESILATO ANEMIA FALCIFORME TRANSPORTER GENES DASATINIB BCR/ABL GENE NILOTINIB MOLECULAR